SCHEMBL4376286

SCHEMBL4376286

CC1CCN(CCCC(NC(=O)Nc2nccs2)c2ccc(C(=O)Nc3ccccc3NC(=O)OC(C)(C)C)nc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.44
MAPT P10636 1/20 0.42
UBE2M P61081 1/20 0.39
DCUN1D1 Q96GG9 1/20 0.39
CYP2D6 P10635 2/20 0.36
OPRK1 P41145 2/20 0.36
CCR2 P41597 2/20 0.36
ADORA2A P29274 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HRH1 P35367 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KCNA5 P22460 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4233301 0.93 METAP1 (0.45) METAP1UBE2MDCUN1D1ADORA2ATSHR
SCHEMBL4224157 0.91 CASR (0.43) METAP1UBE2MDCUN1D1CYP2D6ADORA2A
SCHEMBL4234586 0.89 CASR (0.43) METAP1UBE2MDCUN1D1CYP2D6ADORA2A
SCHEMBL4229354 0.89 METAP1 (0.46) METAP1UBE2MDCUN1D1CCR2ADORA2A
SCHEMBL4223485 0.88 MAPT (0.45) MAPTUBE2MDCUN1D1CYP2D6OPRK1
SCHEMBL3235363 0.86 CCR5 (0.38) MAPTUBE2MDCUN1D1MEN1LMNA
SCHEMBL3221276 0.85 MEN1 (0.42) MEN1KMT2A
SCHEMBL4227705 0.84 METAP1 (0.47) METAP1ADORA2AMEN1LMNAMAPK1
SCHEMBL3228203 0.84 SIGMAR1 (0.40) MAPTCCR2LMNATSHRSMN1; SMN2
SCHEMBL4233242 0.83 METAP1 (0.49) METAP1ADORA2AMEN1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2135620-A1 OCULAR HYPOTENSIVE AGENT COMPRISING COMPOUND CAPABLE OF INHIBITING HISTONE DEACETYLASE AS ACTIVE INGREDIENT Santen Pharmaceutical Co., Ltd (JP) 2009-12-23 EP disclosed